NCT03994978

Brief Summary

The decision to perform a surgical intervention or not after recovery from repeated uncomplicated episodes of acute diverticulitis remains controversial and the literature shows different conflicting approaches based on low-quality evidence.The goal of this trial is to achieve a better understanding of the impact of surgery on bowel function and QoL in patients with recurrent uncomplicated sigmoid diverticulitis in order to develop treatment guidelines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
252

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 19, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 21, 2019

Completed
17 days until next milestone

Study Start

First participant enrolled

July 8, 2019

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
26 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 27, 2022

Completed
Last Updated

January 4, 2023

Status Verified

January 1, 2023

Enrollment Period

3.4 years

First QC Date

June 19, 2019

Last Update Submit

January 2, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in grade of fecal incontinence incontinence score

    Fecal incontinence measured by total "Vaizey-Wexner incontinence score" ranging from 0 to 24; lower values represent better outcome

    change from baseline to 12 months after intervention

  • Change in grade of constipation

    Constipation measured by total "Cleveland constipation score" ranging from 0 to 30; lower values represent better outcome

    change from baseline to 12 months after intervention

Secondary Outcomes (2)

  • Change in gastrointestinal quality of Life: gastrointestinal quality of life score" (GIQLI score)

    change from baseline to 12 months after intervention

  • Change in erectile function

    change from baseline to 12 months after intervention

Study Arms (2)

Surgical group

Patients with uncomplicated recurrent diverticulitis undergoing elective sigmoid resection

Procedure: elective sigmoidectomy

Conservative group

Patients with uncomplicated recurrent diverticulitis with conservative treatment

Interventions

elective sigmoidectomy

Surgical group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with recurrent episodes of diverticulitis with indication of further treatment.The physician decides which therapy (conservative or surgical) will be carried out.

You may qualify if:

  • Patients with recurrent uncomplicated diverticulitis and surgical indication for sigmoid resection
  • Patients with recurrent uncomplicated diverticulitis and non-surgical indication for conservative management
  • Confirmation of at least one episode of acute uncomplicated diverticulitis in computed tomography

You may not qualify if:

  • Patients aged under 18.
  • Patients unable to understand an informed consent.
  • Patients with chronic pain disorder.
  • Patients with sigmoid fistulas
  • Emergency operations.
  • Pregnant women or lactation.
  • Patients with other severe gastrointestinal diseases, such as inflammatory bowel diseases (IBD), carcinoma or immunologic disorders.
  • Patients unable to perform surgery or high-risk patients according to the American Society of Anesthesiology (ASA 4 grade or higher)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Claraspital Basel

Basel, Switzerland

Location

Study Officials

  • Bettina Wölnerhanssen, MD

    St. Clara Research Ltd.

    STUDY CHAIR
  • Daniel Steinemann, MD

    Clarunis

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 19, 2019

First Posted

June 21, 2019

Study Start

July 8, 2019

Primary Completion

December 1, 2022

Study Completion

December 27, 2022

Last Updated

January 4, 2023

Record last verified: 2023-01

Data Sharing

IPD Sharing
Will not share

Locations